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fndosome-to-Golgi retrieval of the mannose 6-phosphate
receptor (MPR) is required for lysosome biogenesis.
Currently, this pathway is poorly understood. Analyses
in yeast identiﬁed a complex of proteins called “retromer”
that is essential for endosome-to-Golgi retrieval of the
carboxypeptidase Y receptor Vps10p. Retromer comprises
ﬁve distinct proteins: Vps35p, 29p, 26p, 17p, and 5p,
which are conserved in mammals. Here, we show that
retromer is required for the efﬁcient retrieval of the cation-
independent MPR (CI-MPR). Cells lacking mammalian
E
 
VPS26 fail to retrieve the CI-MPR, resulting in either rapid
degradation of or mislocalization to the plasma membrane.
We have localized mVPS26 to multivesicular body endo-
somes by electron microscopy, and through the use of CD8
reporter protein constructs have examined the effect of
loss of mVPS26 upon the trafﬁcking of membrane proteins
that cycle between the endosome and the Golgi. The
data presented here support the hypothesis that retro-
mer performs a selective function in endosome-to-Golgi
transport, mediating retrieval of the CI-MPR, but not furin.
 
Introduction
 
Delivery of acid hydrolases to the lysosome/vacuole is initiated
in the TGN or late Golgi and is mediated by specific recep-
tors. In mammalian cells, mannose 6-phosphate receptors
(MPRs) recognize a phosphorylated carbohydrate tag in the
TGN and are then sorted into clathrin-coated vesicles for
delivery to a prelysosomal endosome (Kornfeld and Mellman,
1989; Kornfeld, 1992). Although the mannose 6-phosphate
tag is not used in simple eukaryotes such as yeast, 
 
Saccharomyces
cerevisiae
 
 uses a similar mechanism to sort vacuolar hydrolases
to the vacuole. The Vps10 protein binds vacuolar hydrolases
such as carboxypeptidase Y (CPY) via the pro-domain in the
late Golgi. Receptor and ligand are then sorted into vesicles
for delivery to the prevacuolar compartment (Marcusson et
al., 1994; Cooper and Stevens, 1996).
Two types of MPR exist in mammalian cells, the cation-
independent MPR (CI-MPR) and the cation-dependent
MPR (CD-MPR). Both are type 1 transmembrane proteins
that share some sequence similarity in their luminal domains
(Kornfeld, 1992). Although there is no sequence homology
between Vps10p and the MPRs, fundamentally they perform
an identical task, namely that of sorting newly synthesized
hydrolases into a pathway that will ultimately deliver the
enzymes to the lysosome/vacuole. Recent evidence now
supports a role for the conserved Golgi-associated, 
 
 
 
 ear–
containing ARF-binding proteins (GGAs) in the sorting of
both MPRs and Vps10p at the TGN/late Golgi (Robinson
and Bonifacino, 2001). The VHS domains of GGA proteins
recognize acidic cluster–dileucine signals in the cytoplasmic
tails of MPRs and Vps10p, and can also bind clathrin via their
hinge regions (Mullins and Bonifacino, 2001; Misra et al.,
2002; Shiba et al., 2002). These interactions form the basis
of the sorting of MPRs and Vps10p and their cargo of hydro-
lases into vesicles for eventual delivery to lysosomes/vacuoles.
To maintain efficient sorting and transport of lysosomal/
vacuolar hydrolases, the receptors have to be retrieved from
the endosome. In contrast to the exit of receptor ligands
from the TGN, the process of retrieval is currently poorly
understood at the molecular level. Analyses in yeast have
identified a complex of five proteins that is necessary for the
endosome-to-Golgi retrieval of Vps10p. This complex was
dubbed “retromer” and comprises the Vps35p, 29p, 26p, 17p,
and 5p proteins (Seaman et al., 1997, 1998). Phenotypic
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analysis of the respective mutants along with biochemical
analyses led to the hypothesis that retromer was a candidate
vesicle–coat protein complex that mediates endosome-to-
Golgi retrieval in yeast.
Characterization of yeast retromer has provided many in-
sights into the assembly of the complex and the respective
roles of the individual components. Several lines of evidence,
both genetic and biochemical, favor a role in cargo selection
for Vps35p (Nothwehr et al., 1999, 2000). Vps29p is essen-
tial for the assembly of the retromer complex. Vps5p and
Vps17p are members of the sorting nexin (Snx) family of
proteins, and due to the intrinsic self-assembly activity of
Vps5p, it was suggested that theVps5p–Vps17p complex
may promote vesicle budding (Seaman et al., 1998). Vps26p
plays a crucial role in directing the interactions of Vps35p
and helps stabilize the retromer complex (Reddy and Sea-
man, 2001).
Significantly, retromer is highly conserved and an analo-
gous complex has been identified in mammalian cells (Ren-
frew-Haft et al., 2000). SNX1, the mammalian homologue
of Vps5p, associates with the cytoplasmic tails of several
proteins that traffic in the endocytic system, including the
EGF receptor and the transferrin receptor (TfnR; Kurten
et al., 1996; Renfrew-Haft et al., 1998). Does this mean
that mammalian retromer mediates endosome-to-Golgi re-
trieval? This question has yet to be addressed directly, but it
has been proposed that mammalian retromer is likely to
function in an endosome-to-Golgi retrieval pathway with
cargoes yet unknown (Pfeffer, 2001). Aside from retromer,
other candidate molecules that could mediate the retrieval
of the MPRs are TIP47 (Diaz and Pfeffer, 1998) with rab9
(Riederer et al., 1994) and the clathrin adaptor, AP-1
(Meyer et al., 2000).
Here, we have addressed the specific question of the role
of retromer in endosome-to-Golgi retrieval. Using cells de-
rived from transgenic mice that are deleted for mammalian
VPS26 (mVPS26) and through the application of small
interfering RNA (siRNA) to knock down expression of
mVPS26, we show that absence of mVPS26 (and therefore
functional retromer) results in a range of phenotypes consis-
tent with a defect in endosome-to-Golgi retrieval.
 
Results
 
mVPS26 localizes to endosomes
 
To examine the role of retromer in endosome-to-Golgi re-
trieval, we have attempted to address two specific questions.
First, where is retromer localized? And second, which pro-
teins are trafficked in a retromer-dependent pathway? To aid
in answering both these questions, we have created stably
transfected HeLaM cell lines expressing CD8 reporter pro-
teins in which the cytoplasmic tail of CD8 is replaced with
the cytoplasmic tail of a protein of interest. CD8 is an excel-
lent candidate for this purpose, as it is a cell surface protein
normally expressed in cytotoxic T lymphocytes and is not
expressed in HeLaM cells. It is a type I transmembrane pro-
tein and does not appear to have intrinsic targeting informa-
tion in its luminal or transmembrane domain. There are also
many commercially available antibodies against CD8 that
recognize the luminal domain. Therefore, reporter con-
structs were created in which the cytoplasmic tail of CD8
was replaced with the cytoplasmic tails of the CI-MPR, the
CD-MPR, and furin.
In Fig. 1 A, HeLaM cells stably transfected with these
constructs were fixed and double labeled with antibodies
against CD8 (left panels) and mVPS26 (right panels). The
three different CD8 reporters all have slightly different
steady-state localizations. For example, the CD8-furin con-
struct localizes to a perinuclear structure that colocalizes
with TGN46 (unpublished data). The CD8–CD-MPR chi-
mera has a more punctate localization consistent with an en-
dosomal localization. The CD8–CI-MPR reporter has both
endosomal and TGN localization. Extensive colocalization
between mVPS26 and the CD8–CD-MPR construct was
Figure 1. Immunofluorescence localization of mVPS26. (A) HeLaM 
cells stably transfected with the respective CD8 reporter were fixed 
and labeled with polyclonal anti-mVPS26 and monoclonal anti-CD8 
followed by secondary antibodies. Bar, 20  m. (B) HeLaM cells 
stably expressing GFP-rab proteins were fixed and labeled with 
antisera against mVPS26 followed by fluorescently labeled secondary 
antibodies. Bar, 20  m. Arrows indicate coincident labeling. 
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observed and some colocalization between mVPS26 and the
CD8–CI-MPR construct was also apparent, but there was
no significant colocalization between mVPS26 and CD8-
furin. Additionally, we find that antibodies against Snx1 label
very similar structures to those labeled with anti-mVPS26
antibodies, and there is a similar degree of colocalization be-
tween Snx1 and the three CD8 reporters as was observed for
mVPS26 (unpublished data).
The rab family of small GTPases regulates membrane
docking and fusion events throughout the secretory and en-
docytic pathways. Therefore, rab proteins can be used as
markers for particular membranes. For example, rab5 is lo-
calized to early endosomes, whereas rabs 7 and 9 are present
on late endosomes (and some lysosomes) (Pfeffer, 2003).
Using GFP-tagged rab proteins stably expressed in HeLaM
cells, we have compared the localization of mVPS26 to rabs
5, 7, and 9. In Fig. 1 B, we find that there is significant colo-
calization between mVPS26 and GFP-rab5 and modest
colocalization between mVPS26 and GFP-rab7, but very lit-
tle overlap between mVPS26 and GFP-rab9.
We have also determined the localization of mVPS26 and
Snx1 by EM. Attempts to use conventional cryo-EM to lo-
calize mVPS26 were unsuccessful. Therefore, we developed
a method to allow the pre-embedding labeling of mVPS26.
In Fig. 2, a montage of images is shown. Antibodies against
both mVPS26 (a–c) and Snx1 (d and e) labeled structures
that had morphology typical of endosomes. Arrows indicate
where tubular–vesicular elements are labeled with the anti-
Snx1 antibody.
 
Loss of mVPS26 expression results in altered 
CI-MPR localization
 
The localization data are consistent with a role for retromer
in endosome-to-Golgi retrieval. To examine this possibility
more directly, we used cell lines lacking mVPS26 to deter-
mine the role of retromer in membrane trafficking. Cells de-
rived from transgenic mVPS26
 
 
 
/
 
 
 
 mice were analyzed along
with cells from homozygous wild-type mice. Additionally,
we used siRNA to knock down the expression of mVPS26
in HeLaM cells. In Fig. 3 A, the expression of mVPS26 is
examined and compared with a control protein (actin). No
expression of mVPS26 was detected in the mVPS26
 
 
 
/
 
 
 
cells. Similarly, siRNA treatment of the HeLaM cells results
in complete abolition of mVPS26 expression.
Loss of Vps26p in yeast results in a defect in endosome-
to-Golgi retrieval of Vps10p. If mVPS26 functions in an
analogous pathway, the trafficking of the CI-MPR would
be predicted to be affected after loss of mVPS26. Accord-
ingly, we investigated the distribution of the CI-MPR in
mVPS26
 
 
 
/
 
 
 
 cells and also in mVPS26 knock-down cells by
immunofluorescence. In Fig. 3 B, cells labeled with anti-CI-
MPR are shown. There is a dramatic change in the CI-MPR
localization in the mVPS26
 
 
 
/
 
 
 
 cells compared with wild-
type cells with much reduced intensity of labeling and ap-
Figure 2. Electron microscopic localization of mVPS26 and Snx1. HeLaM cells grown in 6-cm dishes were permeabilized by rapid freeze/
thaw. After fixation, mVPS26 or Snx1 was labeled with polyclonal antisera followed by 10-nm colloidal gold anti–rabbit. The cells were 
embedded in Epon and then sectioned to produce  50-nm-thick sections. mVPS26 (a–c) and Snx1 (d and e) are found on multivesicular 
bodies characteristic of endosomal compartments. Bar, 250 nm. Arrows indicate Snx1 localization to tubular–vesicular structures. 
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parently some cell surface labeling of the CI-MPR (indicated
by arrows). In the mVPS26 knock-down cells the change in
CI-MPR localization is more subtle, with CI-MPR labeling
being detected in more dispersed structures no longer re-
stricted to the perinuclear region. To determine if there is
increased cell surface CI-MPR in the mVPS26 knock-down
cells, a more quantitative method was adopted. Cells labeled
with [
 
35
 
S]methionine were treated with exogenous protease.
After lysis, the CI-MPR, TfnR, and an intracellular protein
(Snx1) were immunoprecipitated. In Fig. 3 C, the CI-MPR
becomes susceptible to exogenous protease after mVPS26
knock down, indicating that there is more cell surface CI-
MPR. The TfnR is no more susceptible to proteolysis after
mVPS26 knock down and the intracellular protein Snx1 is
unaffected by addition of the protease, showing that proteol-
ysis was restricted to only cell surface proteins.
Increased cell surface localization of the CI-MPR after
mVPS26 knock down would also be expected to result in in-
creased colocalization of the CI-MPR with early endosomal
markers such as EEA1. This was investigated by double label-
ing control and mVPS26 knock-down cells with antibodies
against the CI-MPR and EEA1. In Fig. 4 D, the control cells
display extensive overlap in the labeling patterns of EEA1 and
mVPS26 (indicated by arrows), but relatively little coinci-
dence between the CI-MPR and EEA1. After siRNA knock
down of mVPS26, the EEA1 distribution is largely un-
changed, but the CI-MPR appears to be redistributed to
EEA1-positive structures (indicated by arrows). These data are
consistent with increased cycling of the CI-MPR between the
cell surface and early endosomes after mVPS26 knock down.
To examine the steady-state levels of the CI-MPR and other
proteins after loss of mVPS26, lysates prepared from unla-
beled cells were subjected to SDS-PAGE and the resulting gel
was stained with Coomassie blue (Fig. 4 A). Steady-state levels
of various proteins were determined by Western blotting. In
Fig. 4 B, consistent with the data from the metabolic labeling
experiment (Fig. 3 A), mVPS26 was undetectable in the
mVPS26
 
 
 
/
 
 
 
 cells and HeLaM knock-down cells. Levels of
mVPS35 (bottom band) were reduced in the mVPS26
 
 
 
/
 
 
 
cells, but appeared virtually undetectable in the knock-down
Figure 3. Loss of mVPS26 expression results in 
increased cell surface CI-MPR. (A) Cells grown in 
6-cm dishes were labeled with [
35S]methionine 
continuously for 3 h before lysis. mVPS26 or actin 
was immunoprecipitated and then subjected to 
SDS-PAGE and fluorography. Lane 1, wild-type cells; 
lane 2, mVPS26
 /  cells; lane 3, control cells; lane 
4, mVPS26 knock-down cells. (B) Cells were fixed 
and labeled with antibodies against the CI-MPR. 
Arrows indicate CI-MPR localization to the plasma 
membrane. Bars, 20  m. (C) Cells grown in 9-cm 
dishes were labeled overnight with [
35S]methionine. 
After removal from the dish, the cells were treated 
with proteinase K and then were precipitated and 
lysed. The CI-MPR, TfnR, and Snx1 were recovered 
from the resulting lysates and subjected to SDS-
PAGE and fluorography. (D) Control or mVPS26 
knock-down cells were fixed and labeled with 
antibodies against EEA1, mVPS26, or the CI-MPR. 
Arrows indicate coincident labeling. Bar, 20  m. 
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sample. Most interesting is the effect on levels of the CI-MPR.
In the mVPS26
 
 
 
/
 
 
 
 sample it is severely reduced, whereas in
the knock-down sample it appears elevated. Another mem-
brane protein, the TfnR, does not appear to be significantly
affected in the mVPS26
 
 
 
/
 
 
 
 or knock-down samples. Using a
short (15 min) pulse of [
 
35
 
S]methionine followed by a 5-min
chase, we found that there was a 1.4-fold increase in the ex-
pression of the CI-MPR in mVPS26 knock-down cells rela-
tive to a control protein, actin (unpublished data).
Increased expression of the CI-MPR in the mVPS26
knock-down cells could account for the apparent increased
steady-state levels of CI-MPR, but could also have been
masking an increased turnover of the CI-MPR in the knock-
down cells. The apparent loss of the CI-MPR in mVPS26
 
 
 
/
 
 
 
cells indicates that there is a defect in endosome-to-Golgi
retrieval, resulting in the degradation of the CI-MPR in ly-
sosomes. Therefore, we investigated the stability of the CI-
MPR in both the mVPS26
 
 
 
/
 
 
 
 cells and in the mVPS26
knock-down cells by a pulse–chase experiment. Cells were
labeled with [
 
35
 
S]methionine and then chased over a 3-h pe-
riod. The CI-MPR was recovered from lysates prepared at
various time points by immunoprecipitation. After analysis
of CI-MPR levels by SDS-PAGE and fluorography, the data
were converted to graph form (Fig. 5 A). The CI-MPR was
rapidly degraded in mVPS26
 
 
 
/
 
 
 
 cells with a half-life of 
 
 
 
3
h; however, to our surprise, we have found that there was no
increased turnover of the CI-MPR in the mVPS26 knock-
down cells (Fig. 5 B).
A defect in retrieval of the CI-MPR would rapidly lead to
a loss of CI-MPR in the TGN. This could manifest itself as
a loss of proper sorting of lysosomal hydrolases. This is in-
deed the case in yeast when CPY sorting in retromer mu-
tants is measured. A well-characterized lysosomal hydrolase
in mammalian cells is cathepsin D. Sorting of cathepsin D
in the TGN requires the MPRs. Therefore, we measured ca-
thepsin D maturation in control and mVPS26 knock-down
cells. As shown in Fig. 6, mVPS26 knock down results in a
severe defect in cathepsin D maturation, with almost no ma-
ture cathepsin D detectable after a 3-h chase.
 
Loss of mVPS26 causes a selective endosome-to-Golgi 
retrieval defect
 
The lack of retrieval of the CI-MPR in mVPS26 knock-down
cells, which is indicated by the increased cell surface levels of
the CI-MPR and the lack of cathepsin D maturation, was fur-
Figure 4. Steady-state levels of the CI-MPR are affected after loss 
of mVPS26. (A) Lysates from the wild-type and mVPS26
 /  mouse 
cells and lysates from the control and mVPS26 knock-down HeLaM 
cells were prepared and electrophoresed on a 10% polyacrylamide 
gel. The gel was stained with Coomassie blue. (B) Similar gels to the 
one shown in A were transferred onto nitrocellulose and then were 
Western blotted with various antibodies followed by 
125I-protein A. 
Lane 1, wild-type cells; lane 2, mVPS26
 /  cells; lane 3, control cells; 
lane 4, mVPS26 knock-down cells.
Figure 5. The CI-MPR is unstable in the mVPS26
 /  
cells. (A) Cells grown in 3-cm dishes were pulse 
labeled with [
35S]methionine for 1 h and then 
chased for 0, 1, 2, or 3 h. The cells were lysed and 
the CI-MPR was recovered by immunoprecipitation 
and then subjected to SDS-PAGE and fluorography. 
The signal on the resulting film was quantified and 
expressed as a percentage of the signal at time 0. 
The data from four experiments were averaged 
together and are shown in the graph. The error bars 
are SDs. The bottom panels are representative of 
the data obtained and show the instability of the 
CI-MPR in the mVPS26
 /  cells. (B) The CI-MPR 
stability experiment was repeated as described 
above using control and mVPS26 knock-down 
cells. There is no apparent instability of the CI-MPR 
after mVPS26 knock down. 
116 The Journal of Cell Biology 
 
|
 
 
 
Volume 165, Number 1, 2004
 
ther investigated using the CD8 reporter constructs. Stably
transfected cells expressing the CD8–CI-MPR, CD8–CD-
MPR, and CD8-furin were treated with the mVPS26 siRNA.
Cells were fixed and labeled with antibodies against CD8 and
mVPS26. As shown in Fig. 7 A, siRNA knock down of
mVPS26 results in a very significant redistribution of the
CD8–CI-MPR from a predominantly perinuclear localiza-
tion to peripheral structures (compare Fig. 7 A with Fig. 1 A).
The distribution of the CD8–CD-MPR was not significantly
affected, and although the appearance of the CD8-furin chi-
mera was altered, its localization was still predominantly peri-
nuclear. Indeed, it appeared that the CD8-furin labeling and
also the perinuclear CD8–CI-MPR labeling was that of a
fragmented structure. This is particularly noticeable when oc-
casional unaffected cells are found next to cells in which the
knock down of mVPS26 has occurred. Subsequently, we de-
cided to investigate the state of the Golgi complex in cells
lacking mVPS26 using the Golgi marker protein GM130 and
the TGN marker TGN46 as a means of labeling Golgi and
TGN membranes, respectively. In Fig. 7 B, the immunofluo-
resence patterns of GM130 and TGN46 are shown. Loss of
mVPS26 expression results in fragmentation of the Golgi
complex. This is particularly evident in the mVPS26 knock-
down cells, but is also apparent in the mVPS26
 
 
 
/
 
 
 
 cells (un-
published data). By double labeling with antibodies against
TGN46, we find that the CD8-furin construct in mVPS26
knock-down cells remains TGN localized, but the TGN is
now fragmented (Fig. S3 B, available at http://www.jcb.org/
cgi/content/full/jcb.200312034/DC1).
Although the steady-state localization of the CI-MPR and
CD8 reporter constructs strongly suggests a defect in endo-
some-to-TGN retrieval, a more direct assay would be to fol-
low the movement of proteins from endosomes to the TGN.
Using the CD8 reporter constructs, we can examine traffick-
ing from the cell surface to the TGN. In Fig. 8 A, cells ex-
pressing the CD8–CI-MPR construct were labeled with the
anti-CD8 antibody at 4
 
 
 
C to label only the protein at the
surface. After washing away unbound antibody, the cells
were warmed to 37
 
 
 
C and the antibody was chased for 8,
16, and 24 min before the cells were washed again and fixed.
After 8 min, there was extensive colocalization between the
CD8 antibody and mVPS26. By 16 min, much of the anti-
body (and therefore the CD8–CI-MPR) had reached the
perinuclear region, although some colocalization between
the mVPS26 and the CD8 antibody remained. After 24 min
of chase, the antibody had reached the perinuclear region of
the cell and had a typical TGN appearance. By double label-
ing cells with anti-CD8 and anti-TGN46, we confirmed
that after 24 min of chase, the anti-CD8 antibody had
reached the TGN (Fig. 8 C, top panels).
Figure 6. Loss of mVPS26 results in a defect in 
cathepsin D maturation. Cells grown in 3-cm dishes 
were pulse labeled with [
35S]methionine for 15 min 
and then chased for 0, 1, 2, or 3 h. At the end of 
the chase, the media was removed and the cells 
were lysed. Cathepsin D was immunoprecipitated 
from both the intracellular (I) and extracellular (E) 
(media) fractions and subjected to SDS-PAGE and 
fluorography.
Figure 7. CD8 reporter localization and Golgi fragmentation 
after loss of mVPS26 expression. (A) Cells that had been treated with 
mVPS26 knock-down siRNA were fixed and labeled with antibodies 
against CD8 and mVPS26 (as in Fig. 1 A). Bar, 20  m. (B) Control 
cells and mVPS26 knock-down cells labeled with anti-GM130 and 
anti-TGN46. Bar, 20  m. 
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Therefore, the movement of the CD8–CI-MPR from
the cell surface to the TGN involved passage through an
mVPS26-positive compartment. In Fig. 8 B, the experiment
is repeated in mVPS26 knock-down cells. Loss of mVPS26
expression resulted in the CD8–CI-MPR accumulating in
peripheral structures close to the plasma membrane. After
24 min, some of the CD8 antibody had reached the perinu-
clear region, but a significant proportion remained in pe-
ripheral structures. The perinuclear localized anti-CD8 is in-
deed a region of the TGN, as confirmed by double labeling
with anti-TGN46 (Fig. 8 C, bottom panels), but the TGN
had become fragmented in the mVPS26 knock-down cells,
resulting in altered morphology of the TGN. The peripheral
structures containing the anti-CD8 antibody were found
to be positive for the Snx1 protein (Fig. 8 D), indicating
that the CD8–CI-MPR was retained in endosomes after
mVPS26 knock down.
Loss of mVPS26 results in a defect in the retrieval of en-
dogenous CI-MPR and also the CD8–CI-MPR reporter.
Are there other proteins that cycle between the endosome
and TGN in a retromer-dependent manner? To answer this
question, we made another CD8 reporter, this time with the
tail of sortilin. Sortilin is a homologue of the Vps10 protein
(Petersen et al., 1997) and is believed to have a similar traf-
ficking itinerary to the CI-MPR. In Fig. 8 E, the anti-CD8
uptake assay was performed on cells stably transfected with
CD8-sortilin. In control cells (top panels), the antibody is
endocytosed and (after 24 min of chase) delivered to the
TGN. After mVPS26 knock down, the endocytosed anti-
body accumulates in peripheral structures that have a similar
Figure 8. Antibody uptake experiments demonstrate a defect in the kinetics of endosome-to-TGN retrieval after mVPS26 knock down. 
(A) Control cells expressing the CD8–CI-MPR were incubated with anti-CD8 antibodies, washed, and then warmed to 37 C for 8, 16, or 24 min 
before fixation. The cells were then labeled with antibodies against mVPS26 followed by secondary antibodies. (B) mVPS26 knock-down 
cells were treated as in A. (C) Cells from A and B that had been chased for 24 min were labeled with antibodies against TGN46. (D) Cells 
from A and B that had been chased for 24 min were labeled with antibodies against Snx1. (E) CD8-sortilin–expressing cells were subjected to 
the anti-CD8 uptake assay. After 24 min of chase, the cells were fixed and labeled with antibodies against mVPS26 followed by secondary 
antibodies. Arrows in A and D indicate coincident labeling. Bars, 20  m. 
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morphology to those observed in CD8–CI-MPR cells (com-
pare Fig. 8 E with Fig. 8 B).
Therefore, loss of mVPS26 expression results in a signifi-
cant effect upon the endosome-to-Golgi retrieval of the
CD8–CI-MPR chimera. The effect on the trafficking of the
CD8–CD-MPR and CD8-furin chimeras was also exam-
ined using the anti-CD8 antibody uptake assay, although
this time by continuous incubation with antibody over 3 h.
Over the 3-h period, the CD8 reporter construct with
bound antibody will reach a steady-state localization. In Fig.
9 A, control cells were incubated with anti-CD8 for 3 h at
37
 
 
 
C. After washes, the cells were fixed and mVPS26 was la-
beled along with the anti-CD8 antibody. The distribution
of the anti-CD8 antibody in the cells expressing the three
CD8 reporter constructs is virtually the same as shown for
the steady-state distribution of the three chimeras in Fig. 1
A. There is some significant colocalization between the
CD8–CI-MPR and mVPS26 and very extensive colocaliza-
tion between the CD8–CD-MPR and mVPS26, but very
little colocalization between CD8-furin and mVPS26. After
mVPS26 knock down (Fig. 9 B), endocytosed anti-CD8 an-
tibody is found in peripheral and some perinuclear struc-
tures in CD8–CI-MPR expressing cells. The CD8–CD-
MPR expressing cells appear to endocytose more anti-CD8
antibody after knock down of mVPS26. This is apparent
when some unaffected cells are compared with cells in which
the mVPS26 knock down has occurred. The overall localiza-
tion of the endocytosed anti-CD8 antibody in CD8–CD-
MPR expressing cells is not any different after mVPS26
knock down. In cells expressing the CD8-furin chimera, en-
docytosed anti-CD8 reaches a perinuclear compartment
that, although fragmented, does correspond to the TGN
and colocalizes with anti-TGN46 (unpublished data).
This experiment indicates that although the CD8–CI-
MPR reporter requires mVPS26 for its retrieval, CD8-furin
does not. This possibility was investigated further using a
cell line with both furin and CI-MPR reporter proteins. By
replacing the CD8-coding region of the CD8-furin reporter
with GFP, a GFP-furin reporter was generated. This was
found to localize to the TGN in an identical fashion to the
CD8-furin reporter. Cells expressing GFP-furin were trans-
fected with CD8–CI-MPR on a different vector. The GFP-
furin/CD8–CI-MPR transfected cells were subjected to the
anti-CD8 uptake experiment after siRNA knock down of
mVPS26. In Fig. 9 C, in control cells, the anti-CD8 (i.e.,
CD8–CI-MPR) is endocytosed and delivered to the TGN
where it colocalizes precisely with GFP-furin (top panels).
After mVPS26 knock down (bottom panels), the endocy-
tosed anti-CD8 is found in peripheral structures and no
longer colocalizes with the GFP-furin (bottom panels).
Figure 9. mVPS26 knock down results in a selective endo-
some-to-Golgi retrieval defect. (A) Control cells expressing 
the CD8 reporter chimeras were incubated at 37 C continu-
ously for 3 h with the anti-CD8 antibody. After washes, the 
cells were fixed and then labeled as in Fig. 8, A and B. (B) As 
in A, but with mVPS26 knock-down cells. (C) Cells expressing 
both GFP-furin and CD8–CI-MPR were used in an antibody 
uptake experiment similar to those in Fig. 8. After 24 min 
of chase, the cells were fixed and labeled with secondary 
antibodies. Bars, 20  m. 
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Together, these data provide compelling evidence that
mVPS26 (and therefore retromer) is required for efficient
retrieval of the CI-MPR from endosomes to the Golgi.
 
Discussion
 
This work has attempted to address the question of
whether  retromer is required for endosome-to-Golgi re-
trieval in mammalian cells. Using cells derived from trans-
genic mVPS26
 
 
 
/
 
 
 
 mice or HeLaM cells in which mVPS26
expression was ablated by siRNA transfection, we have in-
vestigated the trafficking of both endogenous proteins such
as the CI-MPR and chimeric constructs using the luminal
domain of CD8 as a reporter.
Key to understanding the role that retromer plays in
mammalian cells is the localization of retromer itself. We
find that mVPS26 is localized to endosomal membranes that
are positive for rab5 and EEA1. These data are consistent
with the published colocalization between Snx1 and EEA1
(Chin et al., 2001). The EM analysis of mVPS26 and Snx1
localization confirms that mVPS26 is present on multivesic-
ular bodies.
CD8 has been extensively and successfully used in previ-
ous works as a reporter protein for type I transmembrane
proteins such as furin, TGN38, and endolyn (Chapman and
Munro, 1994; Ponnambalam et al., 1994; Ihrke et al.,
2000). The CD8 reporter constructs used here have proven
to be invaluable for these experiments, as they each have a
slightly different steady-state localization. The CD8–CI-
MPR appears to reside in both TGN and endosomal com-
partments, whereas the CD8–CD-MPR and CD8-furin
constructs are restricted to endosomal or TGN localization,
respectively. This difference in steady-state localization of
the three chimeras can only be due to the intrinsic signals
present in the three different cytoplasmic tails of the CD8
reporter constructs, as the transmembrane and luminal do-
mains are identical in each case. As the cytoplasmic tails of
the three chimeras are responsible for the trafficking/local-
ization of the protein, it is logical to assert that interactions
with cytoplasmic machinery such as vesicle coat proteins are
critical to determine the trafficking of the chimeras. So al-
though we do not claim that the trafficking of the CD8–CI-
MPR is exactly identical to the endogenous CI-MPR, the
chimeras do, nevertheless, provide a means of examining the
trafficking of various type I transmembrane proteins present
in the TGN/endocytic system.
The EM localization and colocalization of mVPS26 with
rab5 and EEA1 establishes that mVPS26 is in the “right
place” to mediate endosome-to-TGN retrieval (see also
Fig. S2, available at http://www.jcb.org/cgi/content/full/jcb.
200312034/DC1). To investigate whether retromer has
a role in endosome-to-TGN retrieval, we have used a cell
line derived from mVPS26
 
 
 
/
 
 
 
 transgenic mice (Lee et al.,
1992), and we have succeeded in knocking down mVPS26
expression by RNA interference. The siRNA knock down of
mVPS26 in the HeLaM cells can achieve an almost com-
plete loss of mVPS26 expression such that by Western blot-
ting and metabolic labeling, levels of mVPS26 protein are
undetectable and therefore no different to levels of mVPS26
protein in the mVPS26
 
 
 
/
 
 
 
 cells. Only occasionally are
mVPS26-positive cells observed by immunofluorescence.
Loss of mVPS26 expression has a profound effect upon the
trafficking of the CI-MPR, resulting in a significant increase
in the amount of CI-MPR present at the cell surface and ex-
tensive overlap in the immunofluorescence labeling patterns
of the CI-MPR and EEA1.
If retromer is required for the endosome-to-Golgi retrieval
of the CI-MPR, then redistribution to the cell surface and in-
creased cycling between the plasma membrane and an early
endosome is one of two possible fates of the CI-MPR in ret-
romer-deficient cells. The other possible destination is the ly-
sosome, which would result in increased turnover of the CI-
MPR. This does appear to be the case for the mVPS26
 
 
 
/
 
 
 
cells, which have significantly reduced steady-state levels of
CI-MPR and degrade their CI-MPR with a half-life of 
 
 
 
3 h.
In the mVPS26 knock-down cells there doesn’t appear to be
any increased turnover of the CI-MPR. A possible reason why
there is a lack of turnover of the CI-MPR in the mVPS26
knock-down cells is that there may be more trafficking of the
CI-MPR between endosomes and the plasma membrane and
less delivery of the CI-MPR to lysosomes relative to the
mVPS26
 
 
 
/
 
 
 
 cells. Recent reports by Maxfield and colleagues
have indicated that a significant proportion of the CI-MPR
cycles between the plasma membrane and early endosomes af-
ter being endocytosed (Lin et al., 2004). Additionally, experi-
ments performed over many years have shown that the CI-
MPR localization can differ considerably between cell types
being either predominantly TGN localized or endosomally/
prelysosomally localized (Brown et al., 1986; Brown and Far-
quhar, 1987; Griffiths et al., 1988; Griffiths, 1989).
Even though there is no apparent instability of the CI-
MPR after mVPS26 knock down, there is in fact a signifi-
cant endosome-to-TGN retrieval defect resulting in rerout-
ing of the CI-MPR into other pathways (e.g., endosome to
plasma membrane). This assertion is supported by the fact
that maturation of cathepsin D is completely abolished after
mVPS26 knock down. Again, this is consistent with the
yeast retromer deletion mutants, which all display strong
CPY sorting defects.
When the steady-state localization of the CD8 reporter
constructs was examined after mVPS26 knock down, we
found that the CD8–CI-MPR construct was partially redis-
tributed to peripheral structures, but retained some perinu-
clear labeling in a compartment that was fragmented. The
distribution of the CD8–CD-MPR chimera was not signifi-
cantly affected, but the CD8-furin construct was now also
in a fragmented perinuclear compartment. This fragmented
perinuclear compartment is likely to be the Golgi/TGN, as
labeling with antibodies against GM130 and TGN46 showed
that the Golgi complex fragments as a consequence of the loss
of mVPS26 (see also Fig. S1, available at http://www.jcb.org/
cgi/content/full/jcb.200312034/DC1). It is worth noting
that although fragmented, the TGN/Golgi remains very
much restricted to the perinuclear region of the cell. The
cause of this fragmentation is not clear, but may be due to a
defect in endosome-to-TGN retrieval of SNARE proteins
that are required for homotypic Golgi membrane fusion. This
is currently being investigated. Golgi fragmentation appeared
less severe in the mVPS26
 
 
 
/
 
 
 
 cells possibly due to some form
of adaptation that has occurred after prolonged culture. 
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The steady-state distributions of the CD8 reporters after
mVPS26 knock down suggested that loss of mVPS26 could
have a major impact on endosome-to-Golgi retrieval. How-
ever, the dynamic nature of the TGN/endocytic system re-
quires that the kinetics of transport also be investigated. Us-
ing an antibody uptake assay, we followed the trafficking of
the CD8–CI-MPR from the cell surface to the TGN. In
control cells, the process is rapid and occurs with kinetics
consistent with previously published reports on CI-MPR re-
trieval (Hirst et al., 1998). CD8–CI-MPR at the cell sur-
face is efficiently endocytosed, and after an 8-min chase is
present in a compartment positive for mVPS26. After 24
min, the CD8–CI-MPR has reached the TGN and colocal-
izes with TGN46. In mVPS26 knock-down cells, the CD8–
CI-MPR appears to be efficiently endocytosed, but it is not
rapidly returned to the TGN. Instead, the CD8–CI-MPR
appears to accumulate in structures close to the plasma
membrane. After 24 min, a small minority of CD8–CI-
MPR does appear to be delivered to the fragmented perinu-
clear structures that are positive for TGN46, but the vast
majority of internalized CD8–CI-MPR remains in periph-
eral structures that are positive for Snx1. A CD8-sortilin re-
porter behaved in a similar fashion after mVPS26 knock
down. As sortilin is a mammalian homologue of the yeast
Vps10 protein (Petersen et al., 1997), it would perhaps be
expected to traffic in a similar fashion to Vps10p (i.e., ret-
romer dependent). Additionally, it has been observed that
the tail of Vps10p can functionally substitute for the tail of
the CI-MPR (Dennes et al., 2002). As yeast retromer medi-
ates retrieval of Vps10p, mammalian retromer performs the
same task for the CI-MPR.
Although the kinetics of the CD8–CI-MPR retrieval in
control cells appeared to be rapid, the CD8-furin chimera
took much longer to reach the TGN, requiring a chase of
 
 
 
60 min (unpublished data). It was also difficult to exam-
ine retrieval of the CD8-furin chimera, as very little of the
chimera is present at the cell surface at any one time. There-
fore, prolonged incubation with the anti-CD8 antibody was
used to determine the extent of uptake and to allow the anti-
body to reach its steady-state distribution. Loss of mVPS26
results in an accumulation of the CD8 antibody in periph-
eral endosomal structures in the CD8–CI-MPR chimera-
expressing cells. However, the CD8-furin chimera is endo-
cytosed and delivered to the fragmented compartment
positive for TGN46 (unpublished data).
Therefore, these data suggest that mVPS26 knock down
can affect the trafficking of some proteins far more than oth-
ers. The retrieval of the CD8–CI-MPR (and CD8-sortilin)
reporter is greatly affected, whereas the CD8-furin protein is
only marginally affected, if at all. This hypothesis was con-
firmed by following the uptake of the CD8–CI-MPR re-
porter in cells expressing a GFP-furin chimera. These data
are in line with the current hypothesis that there are two dis-
tinct endosome-to-Golgi retrieval pathways in mammalian
cells (Mallet and Maxfield, 1999). This can also explain why
there is in fact some retrieval of the CD8–CI-MPR to the
TGN after mVPS26 knock down. A parallel pathway, possi-
bly using AP-1 (Meyer et al., 2000), could provide for par-
tial (perhaps kinetically slower) retrieval of the CI-MPR
(and CD8–CI-MPR).
In summary, loss of mVPS26 results in a severe defect in
endosome-to-TGN retrieval of the CI-MPR. mVPS26
could mediate retrieval of the CI-MPR from both early
and late endosomes. This would account for the partial
overlap in the labeling patterns of mVPS26 and GFP-rab7,
and may suggest that retromer-mediated retrieval is part of
the process of endosome maturation. In this scenario, ret-
romer could initiate endosome-to-TGN retrieval of the
CI-MPR at an early endosome, but retrieval would con-
tinue as the endosome matures. The apparent lack of colo-
calization between mVPS26 and GFP-rab9 may indicate
that an additional trafficking step is required for the re-
trieval of the CI-MPR from endosomes. This additional
step would require TIP47 (Diaz and Pfeffer, 1998) and
rab9 (Riederer et al., 1994). Alternatively, retromer and
TIP47/rab9 could function sequentially in endosome-to-
TGN retrieval.
The CD8 reporter constructs have been used to investi-
gate which proteins may be retrieved in a retromer-depen-
dent fashion. The retrieval of the CD8–CI-MPR chimera
depends upon retromer, whereas the trafficking of the CD8-
furin construct does not, probably because of the existence
of a parallel endosome-to-TGN retrieval pathway. An obvi-
ous candidate to mediate this pathway is AP-1 in concert
with the furin-interacting “adaptor” PACS-1 (Crump et al.,
2001; Folsch et al., 2001).
 
Materials and methods
 
Laboratory reagents
 
Most laboratory reagents including tissue culture media were purchased
from Sigma-Aldrich. Restriction enzymes and other molecular biology re-
agents were obtained from New England Biolabs, Inc. Radioisotopes were
purchased from Amersham Biosciences.
 
Antibodies
 
The monoclonal anti-CD8 was obtained from Qbiogene. Anti-GM130 and
anti-EEA1 were purchased from Becton Dickinson, and the anti-TfnR anti-
body was obtained from Zymed Laboratories. Polyclonal anti-actin was
purchased from Sigma-Aldrich, and the polyclonal anti-CI-MPR (Reaves et
al., 1996) was a gift from J. Paul Luzio (University of Cambridge, Cam-
bridge, UK). Anti-cathepsin D antiserum was obtained from DakoCytoma-
tion, and anti-TGN46 was supplied by Serotec. Polyclonal anti-mVPS26,
anti-Snx1, and anti-mVPS35 were produced in house using GST fusion
proteins as antigens. The antisera were subsequently affinity purified using
the respective antigens coupled to CNBr-Sepharose.
 
Microscopy
 
Immunofluorescence microscopy was performed using an epifluorescence
microscope (Axioplan; Carl Zeiss MicroImaging, Inc.) with a Plan-Apo-
chromat 63
 
 
 
 oil immersion lens (Carl Zeiss MicroImaging, Inc.) at RT. The
secondary antibodies were obtained from Molecular Probes, Inc. and were
conjugated to Alexa Fluor
 
®
 
 488 or 594. The image was obtained using a
CCD camera (Princeton Instruments) that was controlled via IP Lab soft-
ware. Images were cropped using Adobe Photoshop
 
®
 
 software.
 
Cell culture, wild-type, and mVPS26
 
   
 
 mouse cells
 
HeLaM cells (Tiwari et al., 1987) were provided by M.S. Robinson (Uni-
versity of Cambridge, Cambridge, UK). Embryonic stem cells derived from
either homozygous wild-type or homozygous mVPS26
 
   
 
 mouse embryos
(Robertson et al., 1992) were provided by F. Constantini (Columbia Uni-
versity, New York, NY). The embryonic stem cells were produced as part
of an experiment to identify genes important for early embryogenesis (Ra-
dice et al., 1991). Upon receipt, the cells were cultured in DME supple-
mented with 10% FCS, 2 mM glutamine, and 1 mM pyruvate, and contain-
ing 0.1 mM 
 
 
 
-mercaptoethanol and penicillin/streptomycin. Wild-type
and mVPS26
 
   
 
 cells were treated identically and were grown over a pe-
riod of several months, passaging as necessary. 
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SDS-PAGE and Western blotting
 
SDS-PAGE and Western blotting were performed as described in Reddy
and Seaman (2001).
 
GFP-rabs and CD8 reporter constructs
 
EST cDNA encoding rab5c, rab7, and rab9 were obtained from the IMAGE
Consortium. The rab cDNAs were amplified by PCR using primers to add a
BglII and an SalI site to the 5
 
 
 
 and 3
 
 
 
 ends, respectively. The PCR products
were then cloned into the pEGFP-C1 vector (CLONTECH Laboratories,
Inc.) for expression as a GFP fusion in mammalian cells. The CD8–CD-
MPR, CD8-furin, and CD8-sortilin constructs were made in a similar fash-
ion. ESTs for the human cDNAs of the CD-MPR, furin, and sortilin were
obtained from the IMAGE Consortium. Primers were designed to PCR
through the region encoding the cytoplasmic tails of the respective pro-
teins. The 5
 
 
 
 primers incorporated an AflII site; the 3
 
 
 
 primers were de-
signed to anneal 3
 
 
 
 to the stop codon. The PCR products were first cloned
using the pCR blunt vector (Invitrogen). After digestion with AflII and either
SpeI or NotI (depending on orientation), the insert was cloned into CD8 in
pBlueScript
 
®
 
 that had been digested with AflII and either XbaI or NotI to
excise the endogenous CD8 cytoplasmic tail. Constructs were sequenced
and then subcloned from pBlueScript
 
®
 
 into the mammalian expression
vector pIRESneo2 (CLONTECH Laboratories, Inc.). To generate the GFP-
furin chimera, the luminal domain of CD8 (downstream of the signal se-
quence) was replaced with GFP. To facilitate production of this construct,
a BamHI site was engineered into the CD8 cDNA 3
 
 
 
 to the signal se-
quence. The luminal region of CD8 was excised by digestion with BamHI
and EcoRV and replaced with GFP, which had a BamHI site introduced at
the 5
 
 
 
 end by PCR.
The CD8–CI-MPR reporter was constructed by subcloning the cDNA
encoding the cytoplasmic tail of the bovine CI-MPR into CD8-pIRESneo2.
The bovine CI-MPR cDNA (provided by H. Davidson, University of Colo-
rado, Denver, CO) was digested with BsrGI, which cuts precisely at the
junction between the transmembrane domain and the cytoplasmic tail. Af-
ter BsrGI digestion, the overhang was filled by T4 polymerase and then the
CI-MPR cDNA was cut with NotI. The fragment corresponding to the tail
was gel isolated and cloned into CD8-pIRESneo2, which had been di-
gested with AflII, blunted, and then digested with NotI. This construct was
also sequenced to confirm the success of the cloning. The constructs in
pIRESneo2 or pEGFP-C1 were transfected into HeLaM cells using Fu-
GENE™ 6 (Roche). Stably transfected cells were selected using 500 
 
 
 
g/ml
G418 (Life Technologies) and were screened for expression of the CD8 re-
porter constructs by immunofluorescence.
 
Pre-embedding labeling EM
 
Cells grown in 6-cm dishes were washed once with cold PBS and then
once with cold glutamate lysis buffer (25 mM Hepes-KOH, pH 7.4, 25 mM
KCl, 2.5 mM magnesium acetate, 5 mM EGTA, and 150 mM potassium
glutamate) before draining on ice for 5 min. The cells were then snap frozen
by immersion in liquid nitrogen and quick thawed by placing the dish on
the bench for 
 
 
 
60 s. The dish was then returned to ice and the cells were
washed once with 2 ml glutamate lysis buffer. Excess buffer was removed
and replaced with 2 ml of 4% PFA in PBS. The cells were then fixed at RT
for 30 min with one change of fixative after 10 min. The cells were then
washed for 5 min each time with 2 ml of the following: PBS containing 1
mg/ml sodium borohydride, PBS containing 5 mg/ml BSA, and then PBS
containing 1 mg/ml BSA. After these washes, the cells were incubated (60
min) with 2 ml PBS containing 30 mg/ml BSA and either anti-mVPS26 or
anti-Snx1 diluted 1:200. After washes with PBS/BSA, the cells were incu-
bated (60 min) with 10-nm colloidal gold anti–rabbit diluted 1:50. After
washes, the cells were fixed again with 2% PFA and 2.5% glutaraldehyde
in 0.1 M cacodylate, pH 7.4, containing 30 mM CaCl2. The cells were then
scraped up, serially dehydrated, and embedded in Epon before sectioning.
siRNA knock downs
siRNA oligos to knock down mVPS26 expression (AAUGAUGGGGAAAC-
CAGGAAA) were obtained from Dharmacon and were resuspended into
water according to the manufacturer’s instructions. HeLaM cells were
grown in 6-well dishes to a confluency of  60–70%. Transfections with
siRNA were performed as in Motley et al. (2003) using one-fifth the amounts
of Opti-MEM
®, Oligofectamine™, and siRNA per well as described.
Metabolic labeling experiments
Cells grown in tissue culture dishes were incubated with methionine-free
DME for 1 h before labeling. After washes, the cells were pulse labeled
with [
35S]methionine in methionine-free DME and then chased with nor-
mal DME plus additions that had been supplemented with 5 mM methio-
nine/1 mM cysteine. The duration of the labeling and chase varied depend-
ing on what type of experiment was being performed. After the chase (in
most cases), the cells were washed with ice-cold PBS and then lysed using
the following buffer: 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA,
1% Triton X-100, 0.1% SDS, and 0.2% sodium azide. The lysate was
cleared by centrifugation at 13,000 g for 5 min and then was transferred to
a fresh tube. Appropriate antibodies were added and allowed to incubate
overnight at 4 C on a rotating wheel. The antibody was then captured us-
ing protein A–Sepharose or protein G–Sepharose (Amersham Biosciences),
washed, dried down, and then resuspended into SDS-PAGE buffer for elec-
trophoresis. The determination of the amount of cell surface CI-MPR
required a slight modification as follows: cells labeled overnight with
[
35S]methionine in 9-cm dishes were gently removed using a nonenzymatic
cell dissociation solution. The cells were recovered by centrifugation, re-
suspended into 2 ml of serum-free DME, equally divided between two
tubes, and then placed in a shaking water bath at 30 C. 10  l proteinase K
(20 mg/ml) was added to one of each pair and allowed to incubate for 15
min. The cells were then transferred to a tube on ice containing 100  l of
100% TCA. After precipitation, the pellet was washed with acetone, dried,
solubilized in 100  l of 50 mM Tris-HCl, pH 7.4, 6 M urea, and 1% SDS
buffer, and was diluted with the lysis buffer above before clearing by cen-
trifugation. Antibodies were added to the resulting supernatant to immuno-
precipitate the CI-MPR, TfnR, or Snx1. Immunoprecipitates were washed
with 1-ml aliquots of four different buffers as described in Reddy and Sea-
man (2001) before desiccation. After resuspension in SDS-PAGE loading
buffer, the samples were subjected to SDS-PAGE and fluorography.
Anti-CD8 uptake assay
HeLaM cells expressing the CD8 reporter constructs were grown to  70%
confluency on 22-mm coverslips. After washing the cells with ice-cold
PBS, the coverslips were placed in the well of a 6-well dish containing 3
ml chilled media and allowed to incubate for 15 min at 4 C. This ensured
that all trafficking had stopped at the time of the antibody incubations. The
coverslips were then washed again in ice-cold PBS, blotted dry, and then
placed over a 100- l drop of DME containing 1  g anti-CD8 antibody.
The coverslip was incubated with the antibody for 30 min at 4 C before
being washed again with cold PBS and then transferred to well of a 6-well
dish containing 3 ml prewarmed media at 37 C. After incubation for either
8, 16, or 24 min, the coverslips were washed and fixed with ice-cold
methanol/acetone. The continuous uptake assay was performed in a simi-
lar manner, except that the cells were incubated for 3 h continuously with
the anti-CD8 antibody and there were no preincubations at 4 C.
Online supplemental material
Fig. S1 A shows lysates from control and knock-down cells subjected to
SDS-PAGE and then Western blotted with antibodies against mVPS26. The
mVPS26b knock down was less effective at eliminating mVPS26 expres-
sion. After knock down of mVPS35, mVPS26 becomes unstable. Fig. S1 B
shows control and knock-down cells labeled with antibodies against
mVPS26 and GM130. Golgi fragmentation was observed after mVPS26b
knock down and mVPS35 knock down, but with less frequency. Fig. S2
shows control and mVPS26 knock-down cells incubated with serum-free
media for 30 min before incubation with fluorescent transferrin for 10 min.
The cells were then fixed and labeled with antibodies against mVPS26. Af-
ter mVPS26 knock down, transferrin uptake appears normal. Fig. S3 (A and
B) shows control, mVPS26 knock-down, and mVPS35 knock-down cells
expressing either CD8–CI-MPR (A) or CD8-furin (B) fixed and labeled with
antibodies against CD8 and TGN46. Knock-down of mVPS26 or mVPS35
results in a defect in the retrieval of the CD8–CI-MPR but not the CD8-
furin reporter. Online supplemental material available at http://www.jcb.
org/cgi/content/full/jcb.200312034/DC1.
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